VolitionRx Ltd. (VNRX) Starts Presentation at 2nd Annual Marcum MicroCap Conference
VolitionRx is a life sciences company focused on presenting its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. The company’s development activities are currently centered in Belgium with a focus on bringing its diagnostic products to market first in Europe, then the United States, and then expanding worldwide. For more information visit the company’s Web site at www.volitionrx.com
Let us hear your thoughts below:
The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in
Marcum MicroCap. Bookmark the
permalink.
